Ignite Creation Date:
2025-12-24 @ 4:36 PM
Ignite Modification Date:
2026-03-01 @ 6:28 AM
Study NCT ID:
NCT02875366
Status:
COMPLETED
Last Update Posted:
2019-06-17
First Post:
2016-08-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of the Effects of Lumacaftor/Ivacaftor (LUM/IVA) on Exercise Tolerance in Subjects With Cystic Fibrosis (CF), Homozygous for the F508del-CFTR Mutation
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09
Start Date Type:
ACTUAL
Primary Completion Date:
2017-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-15
First Submit QC Date:
None
Study First Post Date:
2016-08-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-09-30
Results First Submit QC Date:
None
Results First Post Date:
2019-06-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-18
Last Update Post Date:
2019-06-17
Last Update Post Date Type:
ACTUAL